JP2010515682A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010515682A5 JP2010515682A5 JP2009544925A JP2009544925A JP2010515682A5 JP 2010515682 A5 JP2010515682 A5 JP 2010515682A5 JP 2009544925 A JP2009544925 A JP 2009544925A JP 2009544925 A JP2009544925 A JP 2009544925A JP 2010515682 A5 JP2010515682 A5 JP 2010515682A5
- Authority
- JP
- Japan
- Prior art keywords
- zileuton
- daily dose
- administered
- pharmaceutical composition
- per day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87927307P | 2007-01-05 | 2007-01-05 | |
| PCT/US2008/000101 WO2008085875A2 (en) | 2007-01-05 | 2008-01-04 | R-zileuton for use in conditions associated with increased 5-lipoxygenase and/or leukotriene activity (eg asthma) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010515682A JP2010515682A (ja) | 2010-05-13 |
| JP2010515682A5 true JP2010515682A5 (enExample) | 2011-03-03 |
Family
ID=39339861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009544925A Pending JP2010515682A (ja) | 2007-01-05 | 2008-01-04 | 喘息などの５−リポキシゲナーゼ活性上昇および／またはロイコトリエン活性上昇に関連する状態における使用のためのｒ−ジロートン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100273868A1 (enExample) |
| EP (1) | EP2114399A2 (enExample) |
| JP (1) | JP2010515682A (enExample) |
| CN (1) | CN101674823A (enExample) |
| CA (1) | CA2674492A1 (enExample) |
| MX (1) | MX2009007247A (enExample) |
| WO (1) | WO2008085875A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013508305A (ja) * | 2009-10-19 | 2013-03-07 | アミラ ファーマシューティカルズ，インク． | 関節内又は関節周囲の投与のための注射可能な製剤 |
| CN101829075B (zh) * | 2010-04-27 | 2011-07-20 | 中国人民解放军第三军医大学第一附属医院 | 苦柯胺a和苦柯胺b的用途 |
| WO2011137363A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase |
| CN102274213A (zh) * | 2010-06-10 | 2011-12-14 | 北京润德康医药技术有限公司 | 含有r(+)-齐留通的药用组合物 |
| US20140323446A1 (en) * | 2011-08-23 | 2014-10-30 | Cornerstone Therapeutics Inc. | Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients |
| GB201118193D0 (en) | 2011-10-21 | 2011-12-07 | Jagotec Ag | Improvements in or relating to oranic compounds |
| GB201118198D0 (en) | 2011-10-21 | 2011-12-07 | Jagotec Ag | Improvements in or relating to organic compounds |
| CN102429872B (zh) * | 2011-11-25 | 2013-07-10 | 舒泰神（北京）生物制药股份有限公司 | 含齐留通的膜控型缓释微丸及其制备方法 |
| US20170312260A1 (en) * | 2014-10-24 | 2017-11-02 | Launx Biomedical Co., Ltd. | New indication of azelnidipine pharmaceutical composition for treating cancer |
| CN107847468A (zh) * | 2015-05-26 | 2018-03-27 | 纪念斯隆·凯特琳癌症中心 | 铁死亡和谷氨酰胺分解抑制剂及其治疗方法 |
| EP4255418A4 (en) * | 2020-12-01 | 2025-04-23 | Reverspah LLC | METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, CHRONIC BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, AND PULMONARY ARTERIAL HYPERTENSION |
| WO2024044654A2 (en) * | 2022-08-23 | 2024-02-29 | University Of Houston System | Parenteral compositions of zileuton and methods of use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08510252A (ja) * | 1993-05-10 | 1996-10-29 | セプラコール・インコーポレーテッド | 光学的に純粋な（＋）‐ジロイトンを用いた方法および組成 |
| EP2001861A2 (en) * | 2006-02-21 | 2008-12-17 | Critical Therapeutics, Inc. | New crystal forms and pharmaceutical compositions of (+)-r-zileuton |
-
2008
- 2008-01-04 CA CA002674492A patent/CA2674492A1/en not_active Abandoned
- 2008-01-04 CN CN200880004777A patent/CN101674823A/zh active Pending
- 2008-01-04 MX MX2009007247A patent/MX2009007247A/es active IP Right Grant
- 2008-01-04 US US12/521,965 patent/US20100273868A1/en not_active Abandoned
- 2008-01-04 WO PCT/US2008/000101 patent/WO2008085875A2/en not_active Ceased
- 2008-01-04 EP EP08712975A patent/EP2114399A2/en not_active Ceased
- 2008-01-04 JP JP2009544925A patent/JP2010515682A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010515682A5 (enExample) | ||
| RU2685730C1 (ru) | Составы соединений азаиндола | |
| RU2700415C1 (ru) | Ингибиторы репликации вирусов гриппа | |
| JP2013537891A5 (enExample) | ||
| JP2010518122A5 (enExample) | ||
| JP2014506321A5 (enExample) | ||
| JP2010515715A5 (enExample) | ||
| JP2013536825A5 (enExample) | ||
| JP2013519645A5 (enExample) | ||
| JP2013526482A5 (enExample) | ||
| NO332844B1 (no) | Oral doseringsform inneholdende en PDE4-hemmer som aktivt ingrediens og polyvinylpyrrolidon som eksipiens, anvendelse derav og fremgangsmåte for fremstilling av det samme. | |
| JP2012520866A5 (enExample) | ||
| JP2020193206A5 (enExample) | ||
| HRP20171511T1 (hr) | Ivabradin-hidroklorid, oblik iv | |
| JP2013509411A5 (enExample) | ||
| JP2013518914A5 (enExample) | ||
| JP2010500284A5 (enExample) | ||
| JP2011157375A5 (enExample) | ||
| JP2007500176A5 (enExample) | ||
| US9084807B2 (en) | Composition comprising ligustroflavone, rhoifolin and hyperin and its pharmaceutical application | |
| CN105693805A (zh) | 一种胆酸类小檗碱偶合物的制备及医药用途 | |
| CN101891785A (zh) | 金丝桃苷的提取方法及其制备药物的用途 | |
| CN104095858A (zh) | 闭花木酮Cleistanone的O-(哌啶基)乙基衍生物在制备抗慢性阻塞性肺病药物中的应用 | |
| JP2010527354A5 (enExample) | ||
| UY31896A (es) | Derivados de 5-(4-metanosulfonil-fenil)-tiazol para el tratamiento de enfermedades inflamatorias agudas y crónicas |